You are here: Industry Insights > COVID-19 vaccine

News List

GSK, CureVac Enter New €150M COVID Vax Pact contractpharma
February 04, 2021
GSK will support the manufacture of up to 100 million doses of CureVac’s first generation COVID-19 vaccine candidate CVnCoV in 2021.
Mexico authorises emergency use of Russia’s Sputnik V vaccine for Covid-19 pharmaceutical-technology
February 04, 2021
Mexican health regulator COFEPRIS has authorised Russia’s Covid-19 vaccine, Sputnik V, for emergency use after the country entered into a contract to secure millions of vaccine doses.
Aeterna Zentaris signs agreement to evaluate oral Covid-19 vaccine pharmaceutical-technology
February 04, 2021
Aeterna Zentaris has signed an exclusive option agreement with the Julius-Maximilians-University Wuerzburg, Germany, to analyse the latter’s preclinical potential Covid-19 vaccine.
Over 80 people arrested in China for smuggling fake COVID-19 vaccines expresspharma
February 04, 2021
China has arrested over 80 people for smuggling and supplying counterfeit COVID-19 vaccines, amid reports that some of the jabs have already made their way to Africa, the official media reported on Tuesday.
Oxford Kept COVID-19 Vaccine Trial Volunteers in Dark About Dosing Error, Letter Shows expresspharma
February 04, 2021
The letter was signed by the trial’s chief investigator, Oxford professor Andrew J. Pollard, and sent to the trial subjects.
New Zealand approves COVID-19 vaccine, warns against nationalism expresspharma
February 04, 2021
The World Health Organization has warned against “hoarding” as a growing number of countries agreed bilateral deals to buy millions of doses of COVID-19 vaccines.
Pfizer targets at least 2 billion COVID-19 vaccine doses this year, sees $15 billion in 2021 from the shots expresspharma
February 04, 2021
Pfizer said that it expects to generate $15 billion, or about a quarter of its total revenue this year, from sales of its COVID-19 vaccine co-developed with German partner BioNTech.
Ocugen, Bharat Biotech announce agreement for commercialisation of Covaxin in US market expresspharma
February 03, 2021
Ocugen is also in active discussions with manufacturers in the US to produce a significant number of doses of COVAXIN to support its US immunisation programme.
Supply order for Covishield vaccine was placed after drug regulator approved it: Govt expresspharma
February 03, 2021
As per protocol, the supply order for COVID-19 vaccines, specifying the number of vaccine doses, was placed with the manufacturer and vaccines were delivered within three days.
In vitro studies demonstrate Pfizer and BioNTech COVID-19 vaccine elicits antibodies that neutralize SARS-CoV-2 with key mutations present in U.K. and South African variants worldpharmanews
February 03, 2021
Pfizer Inc. and BioNTech SE announced results from in vitro neutralization studies of sera from individuals vaccinated with the Pfizer-BioNTech COVID-19 vaccine.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 116 117 Next page